Surgery News

Despite secondary mitral regurgitation in patients with HF being common and associated with mortality, surgical or transcatheter valve repair was seldom performed in this population, researchers reported.

Among nearly 25,000 Swedish patients who received surgical aortic valve replacement, permanent pacemaker implantation within the first 30 days of the procedure increased risk for all-cause mortality and HF hospitalization.

Abiomed announced its right heart pump has received FDA premarket to treat acute right HF for up to 14 days.

At 10 years, patients with three-vessel or left main disease who underwent PCI or CABG were more likely to survive if they were taking optimal medical therapy at 5 years, researchers reported.

Concomitant LAA occlusion in patients undergoing cardiac surgery.

Among patients with stable CAD assigned to an invasive strategy in the ISCHEMIA trial, those who achieved complete revascularization had better clinical and quality of life outcomes, researchers reported.

Fewer than half of patients who underwent left atrial appendage occlusion during open-heart surgery had follow-up imaging to determine whether anticoagulation was still needed, researchers reported.

The mortality rate for women with type A acute aortic dissection remains higher than that for men with the condition, but has improved in the past decade, researchers reported.

The use of CABG has declined dramatically in MI admissions, particularly in STEMI, according to a presentation at the American College of Cardiology Scientific Session.

For this issue, Cardiology Today spoke with Editorial Board Member Jeffrey S. Berger, MD, associate professor of medicine and surgery with appointments in cardiology, hematology and vascular surgery at NYU Grossman School of Medicine and director of the Center for the Prevention of Cardiovascular Disease at NYU Langone Health.